Main Article Content
The study was carried out to determine rate of co-infection between tuberculosis infection and HIV infection in the study population. Record books on tuberculosis (TB) and Human Immunodeficiency Virus (HIV) tests for 15years from year 2002 to 2017 were obtained; data includes the sex and age of the patients at two General Hospitals in Abuja Nigeria to investigate co-infection of the two lethal diseases. A total of 1,412 cases were obtained from University of Abuja Teaching Hospital (UATH) and 392 cases from Gwarimpa General Hospitals. At UATH 536 were positive for both TB and HIV showing a co-infection rate of 37.9%. Among them 275(42.64%) were males and 261(34.03%) were females. Majority 253(48.75) belong to the age group 0f 31-45 years. While at GGH 115 were positive for both TB and HIV, thus showing a co-infection rate of 29.34%, among them 52(32.10) were males and 63(27.40) were females, majority 55(37.93) also belong to the age group of 31-45 years. The high rate of co-infection between Tuberculosis and HIV infections recorded in this study calls for urgent actions to check the lethal combination, especially through the implementation of the WHO’s policy on collaborative TB/HIV activities to reduce the burden of TB among HIV infected individuals.
World Health Organization. Implementing the WHO Stop TB Strategy: A Handbook for National Tuberculosis Control Programmes. Geneva, Switzerland; 2010.
Bishnu RT, Surenda K, Prakash G, Sarala Mallae. Factors associated with high prevalence of pulmonary TB in HIV-infected people in Kathmandu. WHO South-East Journal of Public Health. 2012;1(4):404-411.
Luetkemeyer A. Tuberculosis and HIV. HIV In Site Knowledge Base Chapter; 2013.
Mohan A, Sharma SK. Epidemiology. New Delhi: Jaypee Brothers Medical Publishers; 2001.
Grau I, Pallares R, Tubau F, Schulze MH, Llopis F. Epidemiologic changes in bacteraemia pneumococcal disease in patients with human immunodeficiency virus in the era of highly active antiretroviral therapy. Arch Intern Med. 2005;165(13):1533-1540.
Perriens JH, St Louis ME, Mukadi YB, Brown C, Prignot J, Pouthier F, Portaels F, et al. Pulmonary tuberculosis in HIV-infected patients in Zaire. A Controlled Trial of Treatment for either 6 or 12 Months. New England Journal of Medicine. 2002;332:779–84. [PubMed]
Sharma SK, Mohan A. Extra pulmonary TB. Indian J Med. 2004;120: 316-353.
Zuber A, Shameem M. Manifestation of TB in HIV infected patients. JIACM. 2005;6(4):302-305.
Tadesse S, Taddesse T. HIV co-infection among TB patients in Dabat, Northwest Ethiopia. J. inf, DIS. Imm. 2013;5(3):29-32.
Nwabuko CO, Ejile OA, Chuku A, Nnoli MA, Chukwuonye A. Prevalence of TB-HIV coinfection and relationship between TB and CD4/ESR in HIV patients in Niger Delta region of Nigeria. Dent Med. Sci. 2012;2(4):1-4.
Mukadi YD, Maher D, Harries A. Tuberculosis case fatality rates in high HIV prevalence populations in Sub-Saharan Africa. AIDS. 2002;15:143–52. [PubMed]
Taha M, Deribew A, Tessema F, Assegid S, Duchateu L. Risk factors of of active TB in people living with HIV/AIDS in Southwest Ethiopia: A case control study. Ethiopia J Health Sci. 2011;21(2):131-9.
Olamiran O, Hassan R, Oyovwevotu RA. Prevalence of TB among HIV/AIDS patients in Obafemi Awolowo University Teaching Hospital. Intern Med. 2011; 261:309-329.
World Health Organization. Strategic framework to decrease the burden of TB/HIV. Geneva, World Health Organziaton. WHO/CDS/TB/2002.296; WHO/HIV_AIDS; 2002.